These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28284258)

  • 1.
    Armenta RF; Collins KM; Strathdee SA; Bulterys MA; Munoz F; Cuevas-Mota J; Chiles P; Garfein RS
    Int J Tuberc Lung Dis; 2017 Apr; 21(4):425-431. PubMed ID: 28284258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
    Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
    Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.
    Garfein RS; Rondinelli A; Barnes RF; Cuevas J; Metzner M; Velasquez M; Rodriguez D; Reilly M; Xing J; Teshale EH
    J Urban Health; 2013 Jun; 90(3):516-28. PubMed ID: 22766605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego-Tijuana Border Region.
    Bailey K; Abramovitz D; Rangel G; Harvey-Vera A; Vera CF; Patterson TL; Sánchez-Lira JA; Davidson PJ; Garfein RS; Smith LR; Pitpitan EV; Goldenberg SM; Strathdee SA
    AIDS Behav; 2024 Nov; 28(11):3629-3642. PubMed ID: 39060837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and correlates of obstructive lung disease among people who inject drugs, San Diego, California.
    Koslik HJ; Joshua J; Cuevas-Mota J; Goba D; Oren E; Alcaraz JE; Garfein RS
    Drug Alcohol Depend; 2020 Sep; 214():108158. PubMed ID: 32652379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    Solomon SS; McFall AM; Lucas GM; Srikrishnan AK; Kumar MS; Anand S; Quinn TC; Celentano DD; Mehta SH
    PLoS Med; 2017 Nov; 14(11):e1002460. PubMed ID: 29182638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Correlates of Heroin-Methamphetamine Co-Injection Among Persons Who Inject Drugs in San Diego, California, and Tijuana, Baja California, Mexico.
    Meacham MC; Strathdee SA; Rangel G; Armenta RF; Gaines TL; Garfein RS
    J Stud Alcohol Drugs; 2016 Sep; 77(5):774-81. PubMed ID: 27588536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of HIV/Hepatitis C Virus Co-Infection and Injection Risk Correlations in People Who Inject Drugs in Colombia: A Cross-Sectional Study Using Respondent Driven Sampling.
    Toro-Tobón D; Berbesi-Fernández D
    Subst Use Misuse; 2020; 55(3):414-423. PubMed ID: 31691646
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of latent tuberculosis infection and HIV among people who inject drugs in Iran.
    Radfar SR; Nematollahi P; Tayeri K; Dehghan H; Janani M; Higgs P; Mohsenifar S; Noroozi A
    Drug Alcohol Rev; 2021 May; 40(4):572-579. PubMed ID: 33345378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Illicit Fentanyl Use and Hepatitis C Virus Seroconversion Among People Who Inject Drugs in Tijuana and San Diego: Results From a Binational Cohort Study.
    Friedman JR; Abramovitz D; Skaathun B; Rangel G; Harvey-Vera A; Vera CF; Artamonova I; Muñoz S; Martin NK; Eger WH; Bailey K; Go BS; Bourgois P; Strathdee SA
    Clin Infect Dis; 2024 Oct; 79(4):1109-1116. PubMed ID: 39078273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
    Zhang L; Celentano DD; Le Minh N; Latkin CA; Mehta SH; Frangakis C; Ha TV; Mo TT; Sripaipan T; Davis WW; Quan VM; Go VF
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):550-6. PubMed ID: 25769097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B and C Virus Infections Among Human Immunodeficiency Virus-Infected People Who Inject Drugs in Lahore, Pakistan.
    Mansha S; Imran M; Shah AMUH; Jamal M; Ahmed F; Atif M; Saleem M; Safi SZ; Fatima Z; Bilal Waqar A
    Viral Immunol; 2017 Jun; 30(5):366-370. PubMed ID: 28346804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar.
    Khatib A; Matiko E; Khalid F; Welty S; Ali A; Othman A; Haji S; Dahoma M; Rutherford G
    BMC Public Health; 2017 Nov; 17(1):917. PubMed ID: 29183287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the impact of Mexico's drug policy reforms on people who inject drugs in Tijuana, B.C., Mexico, and San Diego, CA, United States: a binational mixed methods research agenda.
    Robertson AM; Garfein RS; Wagner KD; Mehta SR; Magis-Rodriguez C; Cuevas-Mota J; Moreno-Zuniga PG; Strathdee SA;
    Harm Reduct J; 2014 Feb; 11():4. PubMed ID: 24520885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional study of factors associated with COVID-19 testing among people who inject drugs: missed opportunities for reaching those most at risk.
    Yeager S; Abramovitz D; Harvey-Vera AY; Vera CF; Algarin AB; Smith LR; Rangel G; Artamonova I; Patterson TL; Bazzi AR; Brugman EL; Strathdee SA
    BMC Public Health; 2022 Apr; 22(1):842. PubMed ID: 35473678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.
    Ray Saraswati L; Sarna A; Sebastian MP; Sharma V; Madan I; Thior I; Pulerwitz J; Tun W
    BMC Public Health; 2015 Jul; 15():726. PubMed ID: 26223866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.